After successful catheter ablation for AF, rivaroxaban did not reduce a composite of stroke or systemic embolism vs. aspirin at 36 mo

Ann Intern Med. 2026 Mar;179(3):JC27. doi: 10.7326/ANNALS-25-05629-JC. Epub 2026 Mar 3.

Abstract

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Hematology: [Formula: see text].

MeSH terms

  • Aged
  • Aspirin* / therapeutic use
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / surgery
  • Catheter Ablation*
  • Embolism* / prevention & control
  • Factor Xa Inhibitors* / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use
  • Rivaroxaban* / therapeutic use
  • Stroke* / prevention & control

Substances

  • Rivaroxaban
  • Aspirin
  • Factor Xa Inhibitors
  • Platelet Aggregation Inhibitors